Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402Akira Inoue, Toshihiro Nukiwa, Osamu Ishimoto et al.|Journal of Clinical Oncology|2008Cited by 235
Modulation of Renal Disease in MRL/ <i>lpr</i> Mice Genetically Deficient in the Alternative Complement Pathway Factor BHiroshi Watanabe, Gary S. Gilkeson, Susan A. Boackle et al.|The Journal of Immunology|2000Cited by 205